Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA.
Cancer. 2012 Dec 1;118(23):5793-9. doi: 10.1002/cncr.27631. Epub 2012 May 17.
Changing trends in head and neck cancer (HNC) merit an understanding of the late effects of therapy, but few studies examine dysphagia beyond 2 years of treatment.
A case series was examined to describe the pathophysiology and outcomes in dysphagic HNC survivors referred for modified barium swallow (MBS) studies ≥ 5 years after definitive radiotherapy or chemoradiotherapy (January 2001 through May 2011). Functional measures included the penetration-aspiration scale (PAS), performance status scale-head and neck (PSS-HN), National Institutes of Health Swallowing Safety Scale (NIH-SSS), and MBS impairment profile (MBSImp).
Twenty-nine patients previously treated with radiotherapy (38%) or chemoradiotherapy (62%) were included (median years posttreatment, 9; range, 5-19). The majority (86%) had oropharyngeal cancer; 52% were never-smokers. Seventy-five percent had T2 or T3 tumors; 52% were N+. The median age at diagnosis was 55 (range, 38-72). Abnormal late examination findings included: dysarthria/dysphonia (76%), cranial neuropathy (48%), trismus (38%), and radionecrosis (10%). MBS studies confirmed pharyngeal residue and aspiration in all dysphagic cases owing to physiologic impairment (median PAS, 8; median NIH-SSS, 10; median MBSImp, 18), whereas stricture was confirmed endoscopically in 7 (24%). Twenty-five (86%) developed pneumonia, half requiring hospitalization. Swallow postures/strategies helped 69% of cases, but no patient achieved durable improvement across functional measures at last follow-up. Ultimately, 19 (66%) were gastrostomy-dependent.
Although functional organ preservation is commonly achieved, severe dysphagia represents a challenging late effect that may develop or progress years after radiation-based therapy for HNC. These data suggest that novel approaches are needed to minimize and better address this complication that is commonly refractory to many standard dysphagia therapies.
头颈部癌症(HNC)的治疗趋势不断变化,因此需要了解治疗后的晚期影响,但很少有研究在治疗后 2 年以上检查吞咽困难。
对 2001 年 1 月至 2011 年 5 月间进行过明确的放射治疗或放化疗的吞咽困难 HNC 幸存者进行回顾性研究,这些患者在治疗后 5 年以上进行了改良钡吞咽检查(MBS)。研究描述了这些患者的病理生理学和结果。功能测量包括渗透-吸入量表(PAS)、头颈部功能状态量表(PSS-HN)、美国国立卫生研究院吞咽安全量表(NIH-SSS)和 MBS 损伤量表(MBSImp)。
共有 29 例患者入组,这些患者先前接受过放射治疗(38%)或放化疗(62%)治疗(中位治疗后时间 9 年,范围 5-19 年)。大多数(86%)患者患有口咽癌;52%的患者从不吸烟。75%的患者 T2 或 T3 期肿瘤;52%的患者为 N+。诊断时的中位年龄为 55 岁(范围 38-72 岁)。晚期检查异常包括:构音障碍/声音嘶哑(76%)、颅神经病变(48%)、牙关紧闭(38%)和放射性坏死(10%)。MBS 研究证实所有吞咽困难患者由于生理功能损伤而存在咽部残留和误吸(PAS 中位数 8 分,NIH-SSS 中位数 10 分,MBSImp 中位数 18 分),而内镜下证实 7 例(24%)存在狭窄。25 例(86%)患者发生肺炎,其中一半需要住院治疗。吞咽姿势/策略对 69%的患者有效,但在最后一次随访时,没有患者在所有功能测量指标上均有持久改善。最终,19 例(66%)患者依赖胃造口术。
尽管功能器官保存通常是可以实现的,但严重的吞咽困难是一种具有挑战性的晚期影响,可能在头颈部癌症放射治疗后数年发生或进展。这些数据表明,需要新的方法来最小化和更好地解决这种并发症,这种并发症通常对许多标准的吞咽困难治疗方法都有抵抗力。